AI assistant
Sending…
INSMED Inc — Director's Dealing 2020
Dec 9, 2020
30150_dirs_2020-12-09_a2bfb3d7-a39d-4c37-9ffa-2a4389d08433.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-12-07
Reporting Person: ALTOMARI ALFRED (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-07 | Common Stock | S | 20000 | $39.57 | Disposed | 20938 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 20,000 shares sold at prices ranging from $39.01 to $40.14 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
More from INSMED Inc
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19